English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Pyruvate carboxylase deficiency type A and type C: Characterization of 5 novel pathogenic variants in PC and analysis of the genotype-phenotype correlation.

MPS-Authors
/persons/resource/persons32617

Gapsys,  V.
Research Group of Computational Biomolecular Dynamics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons14970

de Groot,  B.
Research Group of Computational Biomolecular Dynamics, MPI for biophysical chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

3034191.pdf
(Publisher version), 2MB

Supplementary Material (public)

3034191_Suppl_1.pdf
(Supplementary material), 247KB

3034191_Suppl_2.mp4
(Supplementary material), 52MB

3034191_Suppl_3.pdf
(Supplementary material), 188KB

Citation

Coci, E. G., Gapsys, V., Shur, N., Shin‐Podskarbi, Y., de Groot, B., Miller, K., et al. (2019). Pyruvate carboxylase deficiency type A and type C: Characterization of 5 novel pathogenic variants in PC and analysis of the genotype-phenotype correlation. Human Mutation, 40(6), 816-827. doi:10.1002/humu.23742.


Cite as: https://hdl.handle.net/21.11116/0000-0003-3282-1
Abstract
Pyruvate carboxylase deficiency (PCD) is caused by bi-allelic mutations of the PC gene. The reported clinical spectrum includes a neonatal form with early death (type B), an infantile fatal form (type A), and an late onset form with isolated mild intellectual delay (type C). Apart from homozygous stop-codon mutations leading to type B PCD, a genotype-phenotype correlation has not otherwise been discernible. Indeed, patients harboring bi-allelic heterozygous variants leading to PC activity near zero can present either with a fatal infantile type A or with a benign late onset type C form. In this study, we analyzed six novel patients with type A (three) and type C (three) PCD, and compared them with previously reported cases. Firstly, we observed that type C PCD is not associated to homozygous variants in PC. In-silico modeling was used to map former and novel variants associated to type A and C PCD, and to predict their potential effects on the enzyme structure and function. We found that variants lead to type A or type C phenotype based on the destabilization between the two major enzyme conformers. In general, our study on novel and previously reported patients improves the overall understanding on type A and C PCD.